| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |